SCHEMBL7040486

SCHEMBL7040486

COC(=O)c1cc(-c2cccc(C=O)c2)ccc1NC(=O)c1ccc(Cl)cc1Cl

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PPARG P37231 7/20 0.55
PPARA Q07869 4/20 0.54
SMN1; SMN2 Q16637 4/20 0.50
NPC1 O15118 3/20 0.50
HPGD P15428 3/20 0.50
MAPT P10636 3/20 0.50
KMT2A Q03164 3/20 0.50
RAB9A P51151 2/20 0.50
GAA P10253 1/20 0.50
ALDH1A1 P00352 4/20 0.47
TP53 P04637 3/20 0.46
ACLY P53396 1/20 0.44
HDAC8 Q9BY41 2/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 2/20 0.42
LMNA P02545 1/20 0.42
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7037046 0.88 PPARG (0.62) PPARGPPARASMN1; SMN2NPC1HPGD
SCHEMBL7038586 0.87 PPARG (0.61) PPARGPPARASMN1; SMN2NPC1HPGD
SCHEMBL7040693 0.87 PPARG (0.60) PPARGPPARAMAPTKMT2AALDH1A1
SCHEMBL7038678 0.84 PPARG (0.76) PPARGPPARAMAPTALDH1A1TP53
SCHEMBL7038571 0.83 PPARG (0.57) PPARGPPARASMN1; SMN2NPC1HPGD
SCHEMBL7038439 0.83 PPARG (0.55) PPARGPPARASMN1; SMN2NPC1MAPT
SCHEMBL7038602 0.82 PPARG (0.54) PPARGPPARASMN1; SMN2MAPTKMT2A
SCHEMBL7039954 0.82 PPARG (0.80) PPARGPPARANPC1MAPTKMT2A
Lithium SCHEMBL7039319 0.82 PPARG (0.53) PPARGPPARASMN1; SMN2MAPTKMT2A
SCHEMBL7041638 0.82 PPARG (0.60) PPARGPPARASMN1; SMN2NPC1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030073862-A1 Compounds BIOVITRUM AB (SE) 2003-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073862-A1 Compounds PPARG, PPARA, PPARD PPARG 1/4885PPARA 2/4885SMN1; SMN2 2475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.